300 related articles for article (PubMed ID: 19584104)
1. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
Cateau E; Rodier MH; Imbert C
J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
[TBL] [Abstract][Full Text] [Related]
3. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.
Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K
J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120
[TBL] [Abstract][Full Text] [Related]
4. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model.
Martinez LR; Mihu MR; Tar M; Cordero RJ; Han G; Friedman AJ; Friedman JM; Nosanchuk JD
J Infect Dis; 2010 May; 201(9):1436-40. PubMed ID: 20331379
[TBL] [Abstract][Full Text] [Related]
6. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
Shuford JA; Rouse MS; Piper KE; Steckelberg JM; Patel R
J Infect Dis; 2006 Sep; 194(5):710-3. PubMed ID: 16897672
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
Maiolo EM; Oliva A; Furustrand Tafin U; Perrotet N; Borens O; Trampuz A
J Infect; 2016 Mar; 72(3):386-92. PubMed ID: 26723911
[TBL] [Abstract][Full Text] [Related]
9. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
Krishnan-Natesan S; Manavathu EK; Cutright JL; Chandrasekar PH
Int J Antimicrob Agents; 2010 Jul; 36(1):33-6. PubMed ID: 20400270
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Activity of Oleylphosphocholine on
Holtappels M; Swinnen E; De Groef L; Wuyts J; Moons L; Lagrou K; Van Dijck P; Kucharíková S
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061737
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
13. Development of New Strategies for Echinocandins: Progress in Translational Research.
Walsh TJ; Azie N; Andes DR
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S601-3. PubMed ID: 26567276
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.
Bayegan S; Szilágyi J; Kemény-Beke Á; Földi R; Kardos G; Gesztelyi R; Juhasz B; Adnan A; Majoros L
J Chemother; 2011 Apr; 23(2):107-9. PubMed ID: 21571628
[TBL] [Abstract][Full Text] [Related]
15. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
Vande Velde G; Kucharíková S; Van Dijck P; Himmelreich U
Int J Antimicrob Agents; 2018 Jul; 52(1):42-51. PubMed ID: 29572043
[TBL] [Abstract][Full Text] [Related]
16. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
[TBL] [Abstract][Full Text] [Related]
18. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model.
Seidler M; Salvenmoser S; Müller FM
FEMS Yeast Res; 2010 Jun; 10(4):492-5. PubMed ID: 20345899
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of caspofungin against Candida albicans biofilms.
Bachmann SP; VandeWalle K; Ramage G; Patterson TF; Wickes BL; Graybill JR; López-Ribot JL
Antimicrob Agents Chemother; 2002 Nov; 46(11):3591-6. PubMed ID: 12384370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
